Search results
Author(s):
Raj Makkar
Added:
5 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid…
View more
Author(s):
David Wheeler
Added:
10 months ago
ERA 2025 - Prof David Wheeler (University College London, London, UK) joins us to discuss outcomes from real-world data investigating cardiovascular and renal outcomes in patients with DKD.Interview Questions:1. How do real-world cardiovascular and renal outcomes compare to clinical trial results, and which data sources are giving us the best insights into DKD outcomes?2. What's the biggest gap…
View more
Author(s):
Muthiah Vaduganathan
Added:
1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each…
View more
Timing of Heart Transplantation & LVADs
Video Series
Timing of Heart Transplantation & LVADs
Author(s):
Espeed Khoshbin, Owais Dar,
Start date:
Nov 05, 2024
Broadcast
Author(s):
Laura Pérez Bacigalupe
,
Paula Bouzón Iglesias
,
Cristina Helguera Amezua
,
et al
Added:
5 days ago
Author(s):
Rosana González Mesa
,
Aaron Álvarez Amigo
,
Alejandro Gullón de la Roza
,
et al
Added:
4 days ago
Author(s):
Nadira Hamid
,
Rahul P Sharma
Added:
5 months ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and…
View more
Author(s):
Kausik Ray
,
Upendra Kaul
,
Srinivasa Rao
,
et al
Added:
4 months ago
Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF
Author(s):
Phong Phan Dinh
,
Tri Huynh Quang Ho
,
Hung Manh Pham
,
et al
Added:
1 year ago
Systematic Review